Skip to main content
. 2021 Apr 7;9(4):e002421. doi: 10.1136/jitc-2021-002421

Figure 2.

Figure 2

Kaplan-Meier survival estimates for progression free survival according to the selected baseline medications within the two cohorts. Pembrolizumab cohort: corticosteroids (A), antibiotics (B), proton pump inhibitors (PPIs) (C). Chemotherapy cohort: corticosteroids (D), antibiotics (E), PPIs (F).